Andere Sprachen PAO Group, Inc.

Aktien

A2DT5J

US6986681004

PAOG

Verzögert OTC Markets Andere Börsenplätze 15:46:24 03.07.2024			% 5 Tage	% 1. Jan.
0,0004 ^USD	0,00 %		-20,00 %	-20,00 %

2022	PURA und PAOG CBD Nutraceutical Zusammenarbeit wird morgen in 420 Update vorgestellt	CI
2022	Puration, Inc. und PAO Group, Inc. bringen nächsten Monat eine CBD-Produktlinie für den 40-Milliarden-Dollar-Markt für Frauengesundheit auf den Markt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PAO : PAOG 2022 SECOND QUARTER REPORT AND DISCLOSURE	14.08.22
PURA and PAOG CBD Nutraceutical Collaboration Highlighted In 420 Update Tomorrow	19.04.22
PURA and PAOG CBD Nutraceutical Collaboration Highlighted In 420 Update Tomorrow	19.04.22
PURA Hemp Crypto Carbon Credit and Asian Expansion On Track	06.04.22
PURA and PAOG On Track To Launch CBD Product Line For $40 Billion Women’s Health Market	05.04.22
PURA Confirms New CBD Product Line For $40 Billion Women’s Health Market	22.03.22
PURA and PAOG To Launch CBD Product Line Next Month For $40 Billion Women’s Health Market	17.03.22
Puration, Inc. and PAO Group, Inc. To Launch CBD Product Line Next Month For $40 Billion Women’s Health Market	17.03.22
PURA Expects To Boost Revenue Entering $17 Billion CBD Nutraceutical Market	14.03.22
PURA and PAOG Plan Sneak Peek Of CBD Nutraceutical Product Line For $17 Billion Market Opportunity	11.03.22
CapitalGainsReport: CBD Beverages Expected to Drive Growth in Broader CBD Market (RLBD, KGKG, PURA, PAOG, HIPH)	09.03.22
PURA and PAOG Plan Joint CBD Nutraceutical Product Line Launch Next Month	08.03.22
Puration, Inc and PAO Group, Inc Plan Joint Cbd Nutraceutical Product Line Launch Next Month	08.03.22
PAOG Expects Increased Visibility For Its CBD Nutraceuticals From USMJ Ecommerce Campaign	03.02.22
PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development	01.02.22
PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development	01.02.22
PAOG Publishes 2022 Strategic Update	28.01.22
PAOG Publishes 2022 Strategic Update	28.01.22
PAOG Cites Research On Hemp Compounds Effectiveness Treating Covid To Advance Pharmaceutical Development	25.01.22
PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For PURA	06.01.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PAO Group, Inc.

Aktien

A2DT5J

US6986681004

PAOG

Andere Sprachen

Filter